Analyst firms · BofA Securities · GRPH

BofA Securities GRPH price target and rating history

Graphite Bio Inc. (GRPH) · Health Care

BofA Securities rates Graphite Bio Inc. (GRPH) Underperform with a $2 price target, as of its latest action on Feb 23, 2023. It has published 3 rating actions on GRPH since July 2021, including 0 upgrades and 2 downgrades.

Current rating
Underperform
Price target
$2
Median target, all firms
Too few
Actions on GRPH
3

BofA Securities price target on GRPH

$7$4.50$220222023202420252026
BofA Securities price target on GRPH, each point a stated target, July 2021 to February 2023. Targets before January 2023 (divided by 5) are adjusted for a stock split, going by the prior target BofA Securities restated.

Every BofA Securities rating on GRPH

Questions about BofA Securities and GRPH

What is BofA Securities's price target for GRPH?
BofA Securities's latest stated price target for Graphite Bio Inc. (GRPH) is $2, from its action on Feb 23, 2023.
What is BofA Securities's rating on GRPH?
BofA Securities rates GRPH Underperform, a bearish rating, as of Feb 23, 2023.
When did BofA Securities last change its view on GRPH?
On Feb 23, 2023, BofA Securities downgrades to Underperform from Neutral, price target $3 to $2.

All BofA Securities ratingsGRPH news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.